The proliferation of ras-transformed syngeneic tumour cells expressing human EpCAM was suppressed in vivo suggesting the potential of VV GA733-2 as a candidate vaccine for patients with CRC (Zaloudik et al, 2002). This evidence concerns the gene EPCAM and neoplasm.